IMMUNOHISTOCHEMICAL DETECTION OF P53 AND BCL-2 PROTEINS IN HASHIMOTOS-THYROIDITIS AND PRIMARY THYROID LYMPHOMAS

被引:25
作者
CHETTY, R [1 ]
OLEARY, JJ [1 ]
BIDDOLPH, SC [1 ]
GATTER, KC [1 ]
机构
[1] UNIV OXFORD,NUFFIELD DEPT PATHOL,OXFORD,ENGLAND
关键词
HASHIMOTOS THYROIDITIS; PRIMARY THYROID LYMPHOMAS; BCL-2; P53;
D O I
10.1136/jcp.48.3.239
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To investigate whether immunohistochemical staining using p53 and/or bcl-2 distinguishes between florid Hashimoto's thyroiditis and low grade mucosa associated lymphoid tissue (MALT) lymphoma of the thyroid. Methods-Ten cases of Hashimoto's thyroiditis and eight of primary thyroid lymphoma were stained with monoclonal antibodies directed against p53 and bcl-2. Results-In Hashimoto's thyroiditis most small lymphoid cells in mantle zones, within the thyroid parenchyma and in lymphoepithelial lesions expressed bcl-2 protein. Very occasional centroblasts in reactive germinal centres were positive for p53, but all other lymphoid cells from cases of Hashimoto's disease were negative for p53. In diffuse, low grade lymphomas bcl-2 protein was uniformly expressed by most tumour cells. However, low grade lymphomas with a follicular pattern did not express bcl-2. The diffuse, low grade lymphomas were negative for p53, while occasional larger cells in the follicular subtype were positive. Both high grade lymphomas were bcl-2 negative but strongly p53 positive. Conclusions-This study indicates that there is an inverse correlation between p53 and bcl-2 immunostaining in thyroid lymphomas (low grade lymphomas: bcl-2 positive, p53 negative; high grade lymphomas: bcl-2 negative, p53 positive). Furthermore, immunohistochemical staining for bcl-2 and p53 proteins does not distinguish florid Hashimoto's thyroiditis from diffuse, low grade thyroid lymphoma.
引用
收藏
页码:239 / 241
页数:3
相关论文
共 12 条
[1]  
AHSTONKEY M, 1995, HISTOPATHOLOGY, V26, P75
[2]  
CULOTTA E, 1994, SCIENCE, V69, P337
[3]   BCL-2 EXPRESSION IN LYMPHOMAS [J].
ISAACSON, PG ;
WOTHERSPOON, AC ;
DISS, TC ;
PAN, LX .
LANCET, 1991, 337 (8734) :175-176
[4]  
PEZELLA F, 1992, BRIT J CANCER, V65, P87
[5]  
PEZZELLA F, 1990, AM J PATHOL, V137, P225
[6]   IMMUNOHISTOCHEMICAL DETECTION OF P53-PROTEINS AND BCL-2-PROTEINS IN NON-HODGKINS-LYMPHOMA [J].
PEZZELLA, F ;
MORRISON, H ;
JONES, M ;
GATTER, KC ;
LANE, D ;
HARRIS, AL ;
MASON, DY .
HISTOPATHOLOGY, 1993, 22 (01) :39-44
[7]   P53 AND BCL-2 EXPRESSION IN HIGH-GRADE B-CELL LYMPHOMAS - CORRELATION WITH SURVIVAL-TIME [J].
PIRIS, MA ;
PEZELLA, F ;
MARTINEZMONTERO, JC ;
ORRADRE, JL ;
VILLUENDAS, R ;
SANCHEZBEATO, M ;
CUENA, R ;
CRUZ, MA ;
MARTINEZ, B ;
GARRIDO, MC ;
GATTER, K ;
AIELLO, A ;
DELIA, D ;
GIARDINI, R ;
RILKE, F .
BRITISH JOURNAL OF CANCER, 1994, 69 (02) :337-341
[8]   ACCUMULATION OF P53 TUMOR SUPPRESSOR GENE PROTEIN - AN INDEPENDENT MARKER OF PROGNOSIS IN BREAST CANCERS [J].
THOR, AD ;
MOORE, DH ;
EDGERTON, SM ;
KAWASAKI, ES ;
REIHSAUS, E ;
LYNCH, HT ;
MARCUS, JN ;
SCHWARTZ, L ;
CHEN, LC ;
MAYALL, BH ;
SMITH, HS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (11) :845-855
[9]   BCL-2 GENE PROMOTES HEMATOPOIETIC-CELL SURVIVAL AND COOPERATES WITH C-MYC TO IMMORTALIZE PRE-B-CELLS [J].
VAUX, DL ;
CORY, S ;
ADAMS, JM .
NATURE, 1988, 335 (6189) :440-442
[10]   SMALL SUBGROUP OF AGGRESSIVE, HIGHLY PROLIFERATIVE PROSTATIC CARCINOMAS DEFINED BY P53 ACCUMULATION [J].
VISAKORPI, T ;
KALLIONIEMI, OP ;
HEIKKINEN, A ;
KOIVULA, T ;
ISOLA, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (11) :883-887